For millions of Americans, living with Type 2 Diabetes is an ongoing challenge. Long-acting basal insulin such as Lantus®, Basaglar®, Humulin N®, Novolin N®, Levemir and Toujeo® are some of the common insulin treatments for Type 2 Diabetes. Many people experience side effects such as low blood sugar and weight gain. Diabetes specialists are hard at work to identify and improve treatments to manage the disease. Support from people living with diabetes is needed to help current and future generations to come.
We are conducting a research study in your area to evaluate an investigational medication for Type 2 Diabetics who are currently using basal insulin and still experiencing difficulty managing their blood sugar.
In order to participate, you must have an existing diagnosis of Type 2 Diabetes and currently be using basal insulin as part of your treatment regiment.